# Ailite Biotechnology (Shanghai) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ailite-biotechnology-shanghai-co

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.alit.com.cn
- Total disclosed funding: $15M
- Latest round: Series A (May 13, 2022)
- Investors on record: 2

## About

Established in 2019 and based in Shanghai, China, Ailite Biotechnology (Shanghai) Co., Ltd. operates as a biotechnology company that focuses on life science instruments and equipment R&D. The core research team of the company has 30 employees. The company awarded as "high tech enterprise certificate", "Shanghai patent pilot enterprise" and Shanghai "specialized and special new" enterprise. The company cooperates with Germany PEA, Roche and Britain ABER. Mr. Rui Chen is the CEO and founder of the company.

The company provides laboratory instruments, testing reagents and production equipment for life sciences and biotechnology industry. The company's products include aseptic control, cell analysis, incubator / stability and biopharmaceutical technical. Cell analysis includes Countstar BioMarine, Countstar BioFerm and The Countstar Altair. Aseptic control includes Stericell dry heat sterilizer, Sterilab and Uniclean. The company's solutions include CAR-T cell therapy, stem cell therapy, antibody and vaccine.

The company will put the funding towards product R&D and layout in series A funding.

## Funding rounds

- Series A, May 13, 2022, $15M — Addor Capital, Loyal Valley Capital

## Investors

- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Series A
- Loyal Valley Capital (https://capitalatlas.ai/funds/loyal-valley-capital) — Series A